Brandywine Global Investment Management, LLC United Therapeutics Corp Transaction History

Brandywine Global Investment Management, LLC

$13.4 Billion
Q4 2024

A detailed history of Brandywine Global Investment Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 27,123 shares of UTHR stock, worth $9.79 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

27,123

Previous 29,083 6.74%

Holding current value

$9.79 Million

Previous $10.4 Million 8.17%

% of portfolio

0.07%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$348.66 - $410.0 $683,373 - $803,600	-1,960 Reduced 6.74%	27,123 $9.57 Million
Q3 2024 Nov 12, 2024	BUY	$311.04 - $363.55 $967,645 - $1.13 Million	3,111 Added 11.98%	29,083 $10.4 Million
Q2 2024 Aug 14, 2024	BUY	$228.26 - $319.04 $5.93 Million - $8.29 Million	25,972 New	25,972 $8.27 Million
Q4 2020 Feb 10, 2021	SELL	$101.87 - $151.79 $13.4 Million - $19.9 Million	-131,194 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$99.9 - $121.13 $617,481 - $748,704	-6,181 Reduced 4.5%	131,194 $13.3 Million
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $516,098 - $700,188	-5,565 Reduced 3.89%	137,375 $16.6 Million
Q1 2020 May 15, 2020	BUY	$79.39 - $115.35 $11.3 Million - $16.5 Million	142,940 New	142,940 $13.6 Million
Q4 2019 Feb 14, 2020	SELL	$78.31 - $95.34 $8,222 - $10,010	-105 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$74.85 - $85.99 $9.51 Million - $10.9 Million	-127,062 Reduced 99.92%	105 $9,000
Q2 2019 Aug 14, 2019	SELL	$76.06 - $120.81 $875,146 - $1.39 Million	-11,506 Reduced 8.3%	127,167 $9.93 Million
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $30,216 - $35,768	282 Added 0.2%	138,673 $16.3 Million
Q4 2018 Feb 14, 2019	BUY	$101.4 - $128.73 $2.64 Million - $3.35 Million	26,035 Added 23.17%	138,391 $15.1 Million
Q3 2018 Nov 14, 2018	BUY	$113.81 - $129.46 $12.7 Million - $14.5 Million	112,021 Added 33439.1%	112,356 $14.4 Million
Q2 2018 Aug 14, 2018	BUY	$101.14 - $118.31 $21,846 - $25,554	216 Added 181.51%	335 $38,000
Q1 2018 May 15, 2018	BUY	$107.21 - $151.94 $1,500 - $2,127	14 Added 13.33%	119 $14,000
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $9.07 Million - $11.6 Million	-76,461 Reduced 99.86%	105 $16,000
Q3 2017 Nov 14, 2017	SELL	$114.6 - $136.81 $5.52 Million - $6.59 Million	-48,144 Reduced 38.6%	76,566 $8.97 Million
Q2 2017 Aug 14, 2017	BUY	N/A	124,710	124,710 $16.2 Million

Others Institutions Holding UTHR

# of Institutions

723

Shares Held

60.9M

Call Options Held

123K

Put Options Held

104K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.

Account

Brandywine Global Investment Management, LLC United Therapeutics Corp Transaction History